choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Anacor Pharmaceuticals IPO

Anacor Pharmaceuticals IPO Newsletter
  • IPO Update: AN2 Therapeutics Seeks $60 Million U.S. IPO 22 Mar 2022 08:50 GMT

    … VP Neglected Diseases at Anacor Pharmaceuticals, a firm that … Technology Fund, RA Capital, Anacor Pharmaceuticals (Pfizer), Brii Biosciences, Biotechnology … ’s enterprise value at IPO (excluding underwriter options) … the lead underwriter and IPOs led by the …

  • AN2 Therapeutics Files For U.S. IPO 08 Mar 2022 19:08 GMT

    … VP Neglected Diseases at Anacor Pharmaceuticals, a firm that was … Technology Fund, RA Capital, Anacor Pharmaceuticals (Pfizer), Brii Biosciences, Biotechnology … Listed bookrunners of the IPO are Cowen, SVB Leerink, … the lead underwriter and IPOs led by the firm …

  • Evolution Of The Biotech IPO Markets From Busted To Booming 21 Sep 2020 13:06 GMT

    … painful: for example, Anacor, acquired later for $ … IPOs today, and hence valuation appreciation. So what changed in the IPO … conviction about an upcoming IPO. Furthermore, bankers competing … structural change: virtual IPO roadshow? While crossover …

  • Tricida IPO: Almost Completed Phase 3 And A Massive Total Addressable Market 08 Jul 2018 20:44 GMT

    … management bring expertise accumulated in Anacor Pharmaceuticals, Inc., Goldman Sachs … the case in pharma IPOs, the company shows stable … much better after the IPO. All the outstanding convertible … IPO, or Eidos (EIDX) IPO for some other examples of pharma IPOs …

  • Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team 03 Aug 2023 13:07 GMT

    … , Inc., where he led its initial public offering and multiple equity and debt … strategy/portfolio planning at Anacor (acquired by Pfizer), Forest (now …

  • Lung-Disease Focused AN2 Therapeutics Files Plans For NASDAQ Debut 07 Mar 2022 20:15 GMT

    … to go public in an initial public offering in which it reportedly hopes … weakened immune system.  See the IPO prospectus here. Its initial product … commercialization rights for epetraborole from Anacor Pharmaceuticals, owned by Pfizer Inc (NYSE …

  • Apollomics, Inc. Strengthens Leadership with Key Hires 22 Jan 2019 12:50 GMT

    … provider, and led their Nasdaq Initial Public Offering as CFO. Prior to Velti … was VP, Clinical Operations of Anacor Pharmaceuticals where she had oversight for … Clinical Operations department. Prior to Anacor, Dr. Vallner was VP, Clinical …

  • Intellia Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results 14 Mar 2017 11:15 GMT

    … , France. Completed a successful initial public offering, securing a strong cash position … Graeme Bell, formerly CFO of Anacor Pharmaceuticals (acquired by Pfizer in 2016 … to proceeds from our initial public offering and concurrent private placements …

  • Intellia Therapeutics Names Graeme Bell Chief Financial Officer 13 Dec 2016 14:20 GMT

    … as Chief Financial Officer at Anacor Pharmaceuticals, Inc., a publicly … in June 2016. At Anacor, he led the finance, … facilities functions. Prior to Anacor, Mr. Bell spent more … private funding, and the initial public offering. Dr. Srivastava is committed …

  • Tricida Could Topple With Lock-Up Expiration 21 Dec 2018 20:21 GMT

    … believe that these pre-IPO shareholders and company insiders … experience comes from positions at Anacor Pharmaceuticals, InteKrin Therapeutics, Goldman Sachs … for Tricida priced its IPO at $19, above … trading subject to the IPO, any significant sales of …

Satisfied with the content?

Continue to create your account.